Trademark Search in Canada

Prelude THERAPEUTICS

View On IC.GC.CA

SEARCHED

on 23 Jun 2021

Last Applicant/ Owned by

Prelude Therapeutics Incorporated

200 Powder Mill RoadExperimental Station E400/3213Wilmington DE 198032907

Serial Number

2012731 filed on 21^st Nov 2019

Correspondent Address

DALE E. SCHLOSSER

(SPRIGINGS INTELLECTUAL PROPERTY LAW)148 Norseman StreetToronto

ONTARIO

M8Z2R4

Prelude THERAPEUTICS

Trademark usage description

research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases excluding research and development of Read More

Vienna Information

1 . 1 . 1

StarsÉtoiles

1 . 1 . 10

Stars with more than four pointsÉtoiles à plus de quatre pointes

1 . 1 . 3

Two starsDeux étoiles

1 . 1 . 6

Concentric starsÉtoiles concentriques

1 . 1 . 25

Other representations of stars, not classified in division 1.11Autres représentations d'étoiles, non classées dans la division 1.11

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

25 . 7 . 20

Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes

25 . 7 . 21

Surfaces or backgrounds covered with straight lines or bandsSurfaces ou fonds couverts de lignes ou de bandes droites

Classification Information

Class [042]
Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases excluding research and development of drugs in the field of human fertility treatment; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases excluding scientific research for medical purposes in the field of human fertility treatment; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases excluding scientific research and development of pharmaceuticals and biopharmaceuticals for human fertility treatment; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases excluding genetic research in the field of human fertility treatment.

Classification kind code

Mark Details

Serial Number

2012731

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 15 on 12^th Oct 2021	Correspondence Created
Submitted for opposition 22 on 23^rd Jun 2021	Search Recorded
Submitted for opposition 20 on 23^rd Jun 2021	Examiner's First Report
Submitted for opposition 223 on 23^rd Jun 2021	Total Provisional Refusal
Submitted for opposition 256 on 21^st Dec 2020	Notification of Possible Opposition Sent
Submitted for opposition 257 on 20^th Feb 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 19^th Feb 2020	Created
Submitted for opposition 31 on 19^th Feb 2020	Formalized
Submitted for opposition 30 on 21^st Nov 2019	Filed
Submitted for opposition 228 on 21^st Nov 2019	International Registration